Recruiting

Single Counseling

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT07218250

Conditions

Breast Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Single Counseling Session

American Cancer Society booklet

Study Details

Brief summary:

The purpose of this study is to see if a Single Counseling Session for Cancer can help reduce psychosocial distress and improve quality of life in people with breast cancer who are waiting to receive ongoing counseling services (outpatient psychotherapy services). The Single Counseling Session for Cancer-which I will refer to as the "study counseling" during this call-is a one-session, 60-minute counseling program designed to reduce anxiety and depression symptoms in people with cancer who are waiting to receive outpatient psychotherapy services. The researchers will look at whether the study counseling is effective in participants and practical (feasible) for them to complete.

Conditions

Breast Cancer

Study ID

NCT07218250

Start date

Jun 4, 2026

Status verified date

Jun, 2026

Completion date

Jun, 2027

Anticipated

Primary completion date

Jun, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patient must have pathologically confirmed breast cancer (per EMR).
  • Patient with localized or advanced cancer (per EMR).
  • Patient is on a waitlist of at least 2 weeks or more for MSK Counseling Center intake and will not complete a New Visit with a clinical psychologist prior to intervention (these patients will be replaced) (per EMR, patient's care team, or self-report)
  • Has not had and is not scheduled to have an appointment with an MSK psychiatrist or MSK Counseling Center advanced practice provider (per EMR, patient's care team, or self-report)
  • Female (per EMR)
  • Age ≥ 18 (per EMR)
  • English fluency - Per self-report: How well do you speak English?
  • Agrees to be audio-recorded (per self-report) NOTE: Participants who report Very well are considered fluent.
  • Lives in New York, New Jersey, Connecticut, or Florida (per self-report).
  • Has no significant psychiatric disturbance sufficient to preclude completion of the assessment measures, interview, or informed consent (i.e., acute psychiatric symptoms which require urgent or extended individual treatment) (per EMR, patient's care team, or study team).
  • Has no presence of cognitive impairment disorder (i.e., delirium, dementia, or traumatic brain injury) sufficient to preclude meaningful informed consent and/or data collection (per EMR, patient's care team, study team, or per self-report of BOMC cognitive test).
  • Has no current active or passive suicidal ideation ((per EMR, patient's care team, study team, per item 9 of the PHQ-9, or the CSSRS).

Study Design

Enrollment

26 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: SSC-C - Single Session Consultation for Cancer

will receive the study counseling

active comparator: PPSB - Psychosocial Patient Support Booklet

will receive an American Cancer Society booklet for review (and no counseling)

Interventions

Single Counseling Session

The one-time counseling session will be a problem-solving focused program that will try to strengthen the belief in the ability to manage the challenges of the cancer diagnosis and treatment

American Cancer Society booklet

called "After Diagnosis: A Guide for Patients and Families" for review. Again, this booklet includes information about cancer, living with cancer, making treatment decisions, talking to others about cancer, cancer treatment, and questions for the cancer care team. It will be given in person or by email.

Primary outcome measure

  • Acceptability (SSC-C participants) [ Time Frame: up to 3 months ]
  • Acceptability (PPSB participants) [ Time Frame: up to 3 months ]

Central Contacts and Locations

Central contacts

Devika Jutagir, PhD

646-888-8361jutagird@mskcc.org

Francesca Gany, MD, MS

646-888-8054

Locations

Memorial Sloan Kettering Basking Ridge (Consent Only)

Recruiting

Basking Ridge, New Jersey, United States, 07920

Contacts

Devika Jutagir, PhD

646-888-8361

Memorial Sloan Kettering Monmouth (Consent Only)

Recruiting

Middletown, New Jersey, United States, 07748

Contacts

Devika Jutagir, PhD

646-888-8361

Memorial Sloan Kettering Bergen (Consent Only)

Recruiting

Montvale, New Jersey, United States, 07645

Contacts

Devika Jutagir, PhD

646-888-8361

Memorial Sloan Kettering Suffolk- Commack (Consent Only)

Recruiting

Commack, New York, United States, 11725

Contacts

Devika Jutagir, PhD

646-888-8361

Memorial Sloan Kettering Westchester (Consent Only)

Recruiting

Harrison, New York, United States, 10604

Contacts

Devika Jutagir, PhD

646-888-8361

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Recruiting

New York, New York, United States, 10065

Contacts

Devika Jutagir, PhD

646-888-8361

Memorial Sloan Kettering Nassau (Consent Only)

Recruiting

Uniondale, New York, United States, 11553

Contacts

Devika Jutagir, PhD

646-888-8361

More Information

Sponsor

Memorial Sloan Kettering Cancer Center

Last update posted

Jun 8, 2026

Last verified

Jun, 2026

Keywords

  • Counseling Session
  • Reduce Depression
  • Reduce Anxiety
  • Reduce Distress
  • 25-281

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2026-06-08.